Medulloblastoma Treatment in Malaysia
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Medulloblastoma?
Medulloblastoma is a malignant tumour of the central nervous system (CNS). It develops in the cerebellum, which is located near the back of the brain.
Children and teenagers under the age of sixteen are primarily affected by medulloblastoma. It can happen to adults. However, it is less common in older people. Adults diagnosed with medulloblastoma often range in age from 20 to 45.
About 437 children and adults in the United States are affected by this uncommon form of cancer yearly. However, it is the most prevalent type of childhood brain tumour. Most cases are diagnosed between the ages of five and nine.
What is the Importance of Timely Treatment?
Early therapy is essential for medulloblastoma to improve survival rates, reduce tumour spread, and maintain brain function. Early management decreases recurrence risk and improves responses to chemotherapy, radiotherapy, and surgery. In addition to enhancing long-term results and quality of life for patients, early therapy also reduces the likelihood of cognitive and developmental deficits, especially in children. Treatment delays raise the possibility of metastases, brain damage, and decreased therapeutic efficacy.
What are the Common Symptoms of Medulloblastoma?
Your age, the size of the tumour, and its stage of development are some variables that can affect the symptoms of medulloblastoma. These symptoms could be caused by a pressure buildup inside your head or the tumour's location. Some warning signs are:
- Pain in the back
- Issues with balance
- Vision changes
- Having trouble walking
- Lightheadedness
- A headache
- Vomiting and feeling sick
- Fatigue
- Incontinence of the urine or bowel (accidents with peeing and pooping)
Causes and Risk Factors of Medulloblastoma
Causes
The underlying cause of medulloblastoma is not entirely known, but it is thought to include mutations in the most essential pathways, such as TP53, SHH, and WNT. Hereditary genetic syndromes, including Li-Fraumeni syndrome, neurofibromatosis type 1, and Gorlin syndrome, predispose individuals. Environmental influences, especially radiation exposure, might also contribute. Medulloblastoma occurs more frequently in young children, particularly in males, but in most cases, there is no known cause.
Risk Factors
Risk factors for medulloblastoma are:
- Age: Most often diagnosed between the ages of 3 to 8.
- Sex: Medulloblastoma is more likely to affect boys than girls.
- Genetic Syndromes: Hereditary disorders such as Li-Fraumeni syndrome, neurofibromatosis type 1, Gorlin syndrome, and Turcot syndrome raise the risk.
- A family history of medulloblastoma or other brain cancers may raise the risk.
- Radiation Exposure: Earlier radiation exposure, especially to the head, increases the risk of tumour forming.
Connect with our advisor for a PRIORITY response
Latest Research and Technologies in the Treatment of Medulloblastoma in Malaysia
Recent research in Malaysia illustrates promising survival rates among young children with medulloblastoma who have been treated with chemotherapy-only protocols. Molecular profiling technology increasingly classifies tumours into subgroups, allowing more personalised treatment approaches. Despite these advances, problems such as limited access to specialised care and radiotherapy continue to impact the overall effectiveness of treatment.
Treatment options for Medulloblastoma
Surgery: If feasible, surgical tumour removal is often the initial step. The goal is to remove as much of the tumour as safely as possible to decrease the likelihood of recurrence.
Radiation Therapy: Following surgery, radiation treatment is frequently employed in an attempt to kill any residual tumour cells. Young children have specific methods used to reduce the effect on immature brain tissue since radiation has long-term side effects.
Gamma Knife Radio Surgery: A non-surgical treatment for medulloblastoma, Gamma Knife radiosurgery is employed to treat residual cancer cells following surgery or for inoperable tumours.
Cost Start From USD 7000 - USD 10000Explore Options
Cyberknife treatment: CyberKnife is an outpatient medulloblastoma treatment that accurately delivers focused radiation to tumours without surgery. It is ideal for tumours that are inoperable or in difficult-to-reach locations.
Cost Start From USD 7000 - USD 15000Explore Options
Chemotherapy: agents eliminate residual cancer cells and lower the threat of metastasis. It is administered before and after surgery or as part of treatment in the high-risk population.
Cost Start From USD 1500 - USD 3500Explore Options
- Magnetic Resonance Imaging (MRI) is the most frequent imaging method for detecting medulloblastomas. It can deliver high-quality pictures of the spinal cord and brain, allowing for the measurement of the tumour's size, location, and potential for spreading.
- Computed Tomography (CT) Scan: If a facility does not have an MRI, a CT scan can be used. It detects the tumour's location and any swelling or bleeding in the brain.
- Biopsy: A tissue sample of the tumour is removed during surgery (or in exceptional instances, by needle biopsy) to ensure that the tumour is a medulloblastoma. The biopsy can be examined histologically and genetically.
- Lumbar Puncture (Spinal Tap): A lumbar puncture can be performed to examine the cerebrospinal fluid (CSF) for tumour cells, which would suggest metastasis to the spinal cord or other parts of the brain.
MediRehab (chain of Rehab centres - Part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsultations and online therapy sessions.
- Physical Therapy (PT): For enhancing motor function, balance, and coordination, physical therapy enables patients to strengthen and become more independent, especially following surgery or radiation involving movement.
- Occupational Therapy (OT): OT aims to assist patients with activities of daily living, such as dressing, eating, and writing, particularly if motor skills or fine motor functions are compromised.
- Speech and Language Therapy: This therapy assists children and adults in regaining communication skills, including speech, language, and swallowing functions, which can be affected by surgery or radiation.
- Cognitive Rehabilitation: Aspects of memory, attention, and problem-solving can be impacted by treatments for medulloblastoma, so cognitive rehabilitation seeks to enhance these abilities and may include specifically designed exercises to improve academic function and daily activities.
- Depending on the severity of the condition, your healthcare professional may prescribe medicine to help control your symptoms and support the treatment plan.
Instantly Connect with our Specialists
Hospitals for Medulloblastoma in Malaysia
Sunway Medical Centre
Kuala Lumpur, Malaysia
Sunway Medical Centre has initiated a comprehensive expansion plan close to its current hospital facility to enhance its ability to provide services to the global market. The new Cancer Radiosurgery Center and Nuclear Medicine Center, which will also house additional Centers of Excellence like the Digestive Health Center and Dialysis Center, marked the completion of Tower C's first phase in October 2016.
Prince Court Medical Centre
Kuala Lumpur, Malaysia
Prince Court is a private medical facility in the center of Kuala Lumpur that has 277 individual beds. Our dedication is to provide you with the best treatment possible from the time you arrive until you depart, healthier and happier. We are well-known for our top-notch facilities, cutting-edge technology, and friendly customer service.
Subang Jaya Medical Centre
Kuala Lumpur, Malaysia
Subang Jaya Medical Center is renowned for pioneering radiation oncology treatments and infrastructure in Malaysia. The hospital also has a state-of-the-art Cancer Radiosurgery Centre (CRC), which is fully furnished with the latest medical technology for cancer detection, monitoring, and treatment.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose Malaysia for Medulloblastoma Treatment?
Malaysia is growing in popularity as a place to treat medulloblastoma because of numerous essential benefits:
- Affordable Healthcare: Reduced costs of treatment relative to Western nations.
- World-Class Facilities: Cutting-edge medical equipment for diagnosis and treatment.
- Experienced Oncologists: Trained experts from the best global institutions.
- Cutting-Edge Treatments: Exposure to the newest treatments and clinical trials.
- Multidisciplinary Care: Holistic therapy by an expert team.
- Shorter Wait Times: Faster access to specialists.
Frequently Asked Questions
Radiation therapy is a crucial treatment for medulloblastoma; it is usually given following surgery to target any cancer cells that may still be present and lower the chance of recurrence. Craniospinal irradiation (CSI) is frequently used to treat the brain and spinal cord since the tumour can spread through the cerebrospinal fluid.
Radiation is essential for high-risk patients, but its use needs to be carefully controlled, especially in young children under three, to prevent long-term neurological problems. Although current methods try to minimise adverse effects, radiation increases survival rates and lowers the chance of relapse when used in conjunction with surgery and chemotherapy.
Medulloblastoma is often treated with chemotherapy, especially in high-risk pediatric cases. Chemotherapy is typically given after surgery and radiation therapy to target any remaining cancer cells and reduce the likelihood of recurrence. This approach is particularly important for enhancing the effectiveness of other treatments or for children who are too young to receive radiation. The combination of radiation, surgery, and chemotherapy improves overall survival rates and decreases the risk of relapse.
Factors such as age, tumour characteristics, and treatment response significantly determine the prognosis for medulloblastoma. Patients classified as high-risk tend to have a lower 5-year survival rate than those considered standard-risk, who typically have a survival rate of around 70–80%. While advancements in surgery, radiation, and chemotherapy have led to improved outcomes, challenges like relapse and long-term side effects remain prevalent. Early diagnosis and individualised treatment plans are crucial for enhancing survival rates.
While medulloblastoma typically spreads within the central nervous system, it can also extend to other body areas. The cerebrospinal fluid (CSF) can move to various parts of the brain and spinal cord. Although less common, it can sometimes reach distant sites such as the lungs or bones. Early detection and treatment are essential to prevent this spread and improve outcomes.
A medulloblastoma tumour's molecular subgroup (WNT, SHH, Group 3, or Group 4) is based on its genetic makeup and influences therapy options. Although Group 3 needs more aggressive therapy, other subgroups, like WNT-driven tumours, are more favourable and may require less aggressive treatment. Genetic testing helps tailor therapy for better outcomes and fewer side effects.
The side effects of medulloblastoma treatment include fatigue, loss of mental function, hair loss, and coordination problems. Although radiation can affect growth and brain function, especially in very young children, surgery can lead to neurological issues. Hair loss, nausea, and a weakened immune system are all potential side effects of chemotherapy. Long-term effects include hearing loss, endocrine problems, and learning difficulties. While improvements in therapy diminish these adverse effects, they can still affect the quality of the patient's life.
In Malaysia, children with medulloblastoma may truly recover with early detection and cutting-edge therapies like chemotherapy, radiation, and surgery. In Malaysia, healthcare institutions offer the newest technologies and specialised pediatric treatment for the best possible recovery. With the proper care and monitoring, many children see long-term improvements.
Medulloblastoma targets brain areas that control memory, learning, and movement, so it can affect neurological and intellectual function. Chemotherapy, radiation, and surgery can affect memory, concentration, and coordination. Tumour location and treatment can result in long-term cognitive impairment and delays in development, particularly in children.
Recovery from medulloblastoma treatment in Malaysia depends on the nature of the treatment and the patient's overall health and takes several months. The primary healing process after surgery can take 4–6 weeks, and the duration of chemotherapy and radiation could extend the healing process. Frequent follow-ups and rehabilitation are required to monitor improvement and regulate side effects for optimal outcomes.
Yes, you can get a second opinion on Medulloblastoma treatment in Malaysia through MediGence. With MediGence, you can connect with highly experienced professionals from top Malaysian hospitals who can provide additional information regarding your diagnosis and treatment options. The platform facilitates easy access to professional help so you can make informed healthcare choices and receive the best care possible.
To find a certified cancer specialist, search MediGence’s website, which offers a list of top-class and internationally trained oncologists from Malaysia's best hospitals. Through MediGence, you can search the profiles of specialists, check their credentials, reviews, and experience, and book online consultations. To get the best care for your condition, the website also assists you in finding the best hospitals and provides personalised assistance for your health requirements.